First Pass

3 stories from 3 sources

Saturday, July 4, 2026

Day’s Recap is unavailable for this topic and date. Feel free to go through our curated list of stories below.

Other Developments

A curated list of other prominent stories from this day.

3:26 PMScienceDaily

A hidden weakness in deadly cancers could lead to powerful new treatments

Summary

Researchers found that aggressive small cell cancers that lose the RB gene become dependent on the protein E2F3 to survive. In lab models, blocking E2F3 halted tumor growth, and the work suggests some existing FDA-approved drugs could be repurposed to target this dependency.

Why it matters

It identifies a practical target in cancers that have long resisted progress and could shorten the path to new treatments by enabling biomarker-driven, repurposing-focused trials.

10:12 AMGothamist

Legionnaires cluster emerging on Upper East Side, NYC officials say

Summary

New York City health officials reported a Legionnaires disease cluster on the Upper East Side with at least 10 confirmed infections. Investigators have not yet identified the source and are continuing environmental testing and case-finding.

Why it matters

Legionella outbreaks can expand quickly when the source is still active, making early identification and water-system control the difference between a contained cluster and a citywide public health event.

1:00 AMBloomberg Markets

Ebola Vaccine Trials Could Start This Year

Summary

With Ebola cases increasing in Congo and Uganda, developers are fast-tracking vaccines aimed at the Bundibugyo strain. IAVI says a candidate could enter human trials by the end of this year.

Why it matters

Earlier trials could shorten the time to a deployable vaccine for a less-common Ebola strain that is driving current outbreaks.

Make it yours

Build Your First Pass.

Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!